Answers are grounded in this paper and cite their sources.
Stem cell preconditioning can enhance survival, trafficking, and paracrine activity, but promising preclinical enhancement has not yet translated into a comparably mature clinical evidence base.To evaluate the product development requirements for preconditioned stem cells and their extracellular vesicles (EVs) products, we propose a pharmaceutical product development framework, and identify priorities for future translational research.We integrated a comparative assessment of major preconditioning strategies and an analysis of registered clinical trials with product development principles.We also examined their derivative EV products derived from preconditioned stem cells and potential applications of artificial intelligence.The registry analysis identified a small, heterogeneous clinical landscape dominated by early-phase trials and limited use of matched unpreconditioned comparators, restricting assessment of the incremental contribution of preconditioning.We proposed a product lifecycle framework linking the quality target product profile to mechanism of action, critical quality attributes, potency assays, process standardization, good manufacturing practice manufacturing, scale-up, comparability, and risk management.For EV products, preconditioned source cell constitutes an upstream process variable, while the administered product requires specific characterization and potency assessment.Priorities included combined preconditioning methods, transparent reporting and validation of artificial intelligence approaches for optimization and monitoring.Stem cell preconditioning should be developed as a controlled manufacturing step, with quality and potency requirements tailored to the product and indication.This framework may guide the development of reproducible, scalable stem cells and EV products, while clinical studies with appropriate comparators remain necessary to establish the added therapeutic value of preconditioning.
No takes yet. Share an insight, caveat, or question.
Su et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: